Pharmacogenetics of psoriasis:<i>HLA-Cw6</i>but not<i>LCE3B/3C</i>deletion nor<i>TNFAIP3</i>polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab - Concepedia

Concepedia

Publication | Closed Access

Pharmacogenetics of psoriasis:<i>HLA-Cw6</i>but not<i>LCE3B/3C</i>deletion nor<i>TNFAIP3</i>polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab

143

Citations

11

References

2013

Year

Marina Talamonti, E. Botti, Marco Galluzzo, Miriam Teoli, Giulia Spallone, Mauro Bavetta, Sergio Chimenti, Antonio Costanzo

British Journal of Dermatology

Abstract

Our observations underline the role of HLA-Cw6 not only as a psoriasis susceptibility gene, but also as a pharmacogenetic marker of response to ustekinumab in psoriasis.

References

	Year	Citations

Page 1